Earnings misses, bad planning, and product-line execution problems are all hitting the retailer, but it's the macro woes that will also hurt its competitors.
After a 2018 high, marijuana stocks are gaining popularity again, but which ones are producing the most green for investors? Here are the charts.
What new management means for Mylan shareholders moving forward.
Pfizer will combine its off-patent drug business with Mylan in the as-yet-to-be-named new company.
A big jump in the market cap of Google's parent is in store thanks to an impressive second-quarter report.
Volatility reigns once again at the electric carmaker, which is seeing JB Straubel depart as chief technology officer.
Big-cap names have been driving the market, but some small-caps could make noise, too.
Watch closely as the government opens a broad antitrust investigation into unidentified leading online technology platforms
The loss of clients is a primary concern here.
It is unclear how a 'libra' denominated transaction might be governed in the future and it might require the creation of an entirely new oversight entity.